BE869640A - Nouveaux acides 2-pyridyl- et 2-pyrimidyl-amino-benzoiques, leur preparation et leur utilisation en tant que medicaments - Google Patents

Nouveaux acides 2-pyridyl- et 2-pyrimidyl-amino-benzoiques, leur preparation et leur utilisation en tant que medicaments

Info

Publication number
BE869640A
BE869640A BE78189801A BE189801A BE869640A BE 869640 A BE869640 A BE 869640A BE 78189801 A BE78189801 A BE 78189801A BE 189801 A BE189801 A BE 189801A BE 869640 A BE869640 A BE 869640A
Authority
BE
Belgium
Prior art keywords
pyrimidyl
pyridyl
amino
preparation
new
Prior art date
Application number
BE78189801A
Other languages
English (en)
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of BE869640A publication Critical patent/BE869640A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
BE78189801A 1977-08-10 1978-08-09 Nouveaux acides 2-pyridyl- et 2-pyrimidyl-amino-benzoiques, leur preparation et leur utilisation en tant que medicaments BE869640A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772735919 DE2735919A1 (de) 1977-08-10 1977-08-10 Neue 2-pyridyl- und 2-pyrimidylaminobenzoesaeuren

Publications (1)

Publication Number Publication Date
BE869640A true BE869640A (fr) 1979-02-09

Family

ID=6016013

Family Applications (1)

Application Number Title Priority Date Filing Date
BE78189801A BE869640A (fr) 1977-08-10 1978-08-09 Nouveaux acides 2-pyridyl- et 2-pyrimidyl-amino-benzoiques, leur preparation et leur utilisation en tant que medicaments

Country Status (32)

Country Link
US (1) US4241068A (fr)
JP (1) JPS5430177A (fr)
AT (1) AT370415B (fr)
AU (1) AU520240B2 (fr)
BE (1) BE869640A (fr)
BG (1) BG30472A1 (fr)
CA (1) CA1111037A (fr)
CH (1) CH649289A5 (fr)
CS (1) CS202506B2 (fr)
DD (1) DD140351A5 (fr)
DE (1) DE2735919A1 (fr)
DK (1) DK148019C (fr)
ES (5) ES472143A1 (fr)
FI (1) FI71555C (fr)
FR (1) FR2400017A1 (fr)
GB (1) GB2002764B (fr)
GR (1) GR65024B (fr)
HU (1) HU179933B (fr)
IE (1) IE47228B1 (fr)
IT (1) IT1107960B (fr)
LU (1) LU80094A1 (fr)
MX (1) MX5672E (fr)
NL (1) NL7808319A (fr)
NO (1) NO152605C (fr)
NZ (1) NZ188101A (fr)
PH (1) PH19117A (fr)
PL (2) PL115778B1 (fr)
PT (1) PT68407A (fr)
SE (1) SE444170B (fr)
SU (2) SU735168A3 (fr)
YU (1) YU40832B (fr)
ZA (1) ZA784501B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3100516A1 (de) * 1981-01-10 1982-08-12 C.H. Boehringer Sohn, 6507 Ingelheim Pyridylaminobenzoesaeuren, ihre herstellung und verwendung
FR2533567A1 (fr) * 1982-09-23 1984-03-30 Ki I Farmakologii 2-(orthocarboxyphenylamino)-6h-pyrimido (2,1-b)-quinazolone-6 et ses derives, leur procede de preparation et leur application therapeutique
US4610991A (en) * 1983-04-18 1986-09-09 Sterling Drug Inc. Antihypertensive pyridylaminobenzamide compounds
JPS60100559A (ja) * 1983-11-05 1985-06-04 Morishita Seiyaku Kk ２−アニリノ−１，６−ジヒドロ−６−オキソ−５−ピリミジンカルボン酸誘導体，その製法及び該化合物を含有する抗アレルギ−剤
US4584379A (en) * 1985-01-22 1986-04-22 Merrell Dow Pharmaceuticals Inc. Isoquinoline thromboxane synthetase inhibitors
ATE68789T1 (de) * 1985-10-16 1991-11-15 Merck Frosst Canada Inc 2-substituierte chinoline.
GB9615950D0 (en) * 1996-07-30 1996-09-11 Univ Warwick Variable reluctance machines
US6022884A (en) 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1064259A (en) * 1963-12-19 1967-04-05 Union Pharma Scient Appl New derivatives of 2-anilino-nicotinic acid and process for their preparation
GB1162287A (en) * 1967-11-07 1969-08-20 Union Pharma Scient Appl New Salts of 2-Anilino-Nicotinic Acids
GB1264798A (fr) * 1968-07-10 1972-02-23
ES416847A1 (es) * 1973-07-12 1976-03-01 Hermes Sa Lab Procedimiento para la obtencion de derivados del acido ni- cotinico.

Also Published As

Publication number Publication date
YU40832B (en) 1986-06-30
FI782039A (fi) 1979-02-11
FR2400017A1 (fr) 1979-03-09
ZA784501B (en) 1980-04-30
HU179933B (en) 1983-01-28
ES480623A1 (es) 1980-01-01
NO152605C (no) 1985-10-23
LU80094A1 (de) 1979-09-07
NZ188101A (en) 1981-01-23
DD140351A5 (de) 1980-02-27
CS202506B2 (en) 1981-01-30
GB2002764A (en) 1979-02-28
YU191678A (en) 1983-01-21
IE781618L (en) 1979-02-10
NO782707L (no) 1979-02-13
DE2735919C2 (fr) 1988-10-27
FI71555B (fi) 1986-10-10
AU3877278A (en) 1980-02-14
MX5672E (es) 1983-12-08
IE47228B1 (en) 1984-01-25
JPS6231704B2 (fr) 1987-07-09
DK148019B (da) 1985-02-04
DK351978A (da) 1979-02-11
ATA549278A (de) 1982-08-15
AU520240B2 (en) 1982-01-21
AT370415B (de) 1983-03-25
PL115889B1 (en) 1981-05-30
PL115778B1 (en) 1981-04-30
PT68407A (de) 1978-09-01
CA1111037A (fr) 1981-10-20
CH649289A5 (de) 1985-05-15
BG30472A1 (en) 1981-06-15
US4241068A (en) 1980-12-23
DK148019C (da) 1985-07-01
NL7808319A (nl) 1979-02-13
NO152605B (no) 1985-07-15
ES475456A1 (es) 1979-05-01
FR2400017B1 (fr) 1983-03-11
ES472143A1 (es) 1979-03-16
GR65024B (en) 1980-06-16
SE7808530L (sv) 1979-02-11
SU735168A3 (ru) 1980-05-15
IT7850642A0 (it) 1978-08-08
JPS5430177A (en) 1979-03-06
GB2002764B (en) 1982-08-04
PL208942A1 (fr) 1979-12-03
SE444170B (sv) 1986-03-24
IT1107960B (it) 1985-12-02
SU886743A3 (ru) 1981-11-30
FI71555C (fi) 1987-01-19
ES475457A1 (es) 1979-11-16
DE2735919A1 (de) 1979-02-22
ES480622A1 (es) 1980-01-01
PH19117A (en) 1986-01-06

Similar Documents

Publication Publication Date Title
FR2329266A1 (fr) Nouveaux amino-benzamides, leur preparation et leur utilisation en tant que medicaments
FR2335229A1 (fr) Nouveaux derives de quinazolone, leur preparation et leur utilisation en tant que medicaments
FR2343731A1 (fr) Nouveaux aminoalcoylheterocycles, procedes pour leur preparation et leur utilisation en tant que medicaments
FR2337718A1 (fr) Nouveaux hydroxy-benzodiheterocycles etherifies, leur procede de preparation et leur application en tant que medicaments
BE854843A (fr) Nouveaux derives d'acides phosphoneux, leur preparation et leur application en tant que medicaments
BE865165A (fr) Nouveaux 1-amino-indanes et leur utilisation comme medicaments
BE863160A (fr) Nouveaux derives aminoalcoxyphenyles, leur preparation et leur utilisation en tant que medicaments
FR2340330A1 (fr) Acides polyvinylbenzenesulfoniques, leur procede de preparation et leur application en tant que medicaments
BE869640A (fr) Nouveaux acides 2-pyridyl- et 2-pyrimidyl-amino-benzoiques, leur preparation et leur utilisation en tant que medicaments
MC1223A1 (fr) Nouveaux derives de 2-imino-imidazolidine,leur preparation et leur application en tant que medicaments
FR2303560A1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
FR2321884A1 (fr) Nouvelles oxazolidinones-(2), leur procede de preparation et leur application en tant que medicaments
BE874683A (fr) Nouveaux derives bicyclo-octaniques leur preparation et leur utilisation comme medicaments
BE847861A (fr) Nouveaux amino-benzamides, leur preparation et leur utilisation en tant que medicaments
LU79949A1 (fr) Nouveaux derives solubles de 2,4-diamino-pyrimidines,leur preparation et leur utilisation en tant que medicaments
BE862275A (fr) Nouveaux acides sulfamoylbenzoiques, leur preparatrion et leur application en tant que medicaments
BE869275A (fr) Nouveaux derives d'esters de vincaminol, leur preparation et leur application en tant que medicaments
BE847373A (fr) Nouveaux derives de cyclohexylphenyle, leur preparation et leur utilisation en tant que medicaments
BE864290A (fr) Nouveaux aryl-hexafuranosides, leur preparation et leur application en tant que medicaments
MC1222A1 (fr) Nouvelles 2,4-diamino-5-benzylpyrimidines,leur preparation et leur application en tant que medicaments
FR2341584A1 (fr) Nouveaux derives de thienothiazine, leur procede de preparation et leur application en tant que medicaments
FR2314707A1 (fr) Nouveaux tetraiodo-terephtalates d'hydroxyalcoyle, leur preparation et leur application en tant que medicaments
BE856157A (fr) Nouveaux n-benzylaminoacides soufred, leur preparation et leur utilisation en tant que medicaments
BE853328A (fr) Nouveaux composes oxothia, leur preparation et leur application en tant que medicaments
BE863843A (fr) Nouveaux derives d'acides benzo-heterocyclylglyoxyliques, leur preparation et leur application en tant que medicaments

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: C.H. BOEHRINGER SOHN

Effective date: 19930831